Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Verrica Pharmaceuticals (VRCA) Other Gross PP&E Adjustments (2021 - 2025)

Verrica Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 5 years, most recently at -$3.5 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$3.5 million for Q4 2025, down 11.4% from a year ago — trailing twelve months through Dec 2025 was -$3.5 million (down 11.4% YoY), and the annual figure for FY2025 was -$3.5 million, down 11.4%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$3.5 million at Verrica Pharmaceuticals, down from $643000.0 in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for VRCA hit a ceiling of $2.9 million in Q3 2022 and a floor of -$3.9 million in Q4 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was $762500.0 (2022), compared with a mean of $381250.0.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 538.66% in 2023 and later surged 494.25% in 2025.
  • Verrica Pharmaceuticals' Other Gross PP&E Adjustments stood at -$781000.0 in 2021, then surged by 212.93% to $882000.0 in 2022, then plummeted by 538.66% to -$3.9 million in 2023, then increased by 19.26% to -$3.1 million in 2024, then dropped by 11.4% to -$3.5 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$3.5 million (Q4 2025), $643000.0 (Q3 2025), and $349000.0 (Q2 2025) per Business Quant data.